Clinical Trials on Systemic Fungal Infections in Belgium

Total 6494 results

Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

Human Influenza

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above

Human Influenza

Belgium
Immune Targeting Systems Ltd

Completed

Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers

Influenza A

Belgium
Solvay Pharmaceuticals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Belgium
LiteVax BV
University Hospital, Ghent; HarmonyCR, Melle, Belgium

Recruiting

Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine (TETRALITE-Ib)

Vaccination Reaction

Belgium
Ziekenhuis Oost-Limburg

Completed

The COGCOV Study in ICU Patients (COGCOV)

Covid19 | Cognitive Impairment

Belgium
University Hospital, Ghent

Completed

Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic

COVID | Fertility Issues | Coronavirus | ART

Belgium
General Hospital Groeninge

Active, not recruiting

Impact of a COVID-19 Related ICU Stay on Mental Health for Patients and Their Relatives (PICOVIDS)

COVID-19 | Mental Health | Critically Ill | Post Intensive Care Syndrome | PICS

Belgium
Pfizer
Valneva Austria GmbH

Completed

Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis

Lyme Borreliosis, Nervous System

Belgium, United States
Jessa Hospital

Completed

Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19

COVID-19

Belgium
Elke Leuridan, MD, PhD
Université Libre de Bruxelles

Recruiting

The Optimal Timing of Vaccination in Pregnancy (MATIMMUNE)

Pertussis/Whooping Cough

Belgium
Universitair Ziekenhuis Brussel

Unknown

poSt Covid-19 Infection centraL Sensitisation 2 (SILENT 2)

Covid19

Belgium
University Hospital, Ghent

Withdrawn

Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

Covid19 | HIV Seropositivity | Immunodeficiency | Vaccination Reaction

Belgium
University Hospital, Antwerp

Withdrawn

Covid-19 Long-term Revalidation Follow-up (Colonel)

Covid19

Belgium
GlaxoSmithKline

Completed

Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine

Infections, Cytomegalovirus

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

Infections, Cytomegalovirus

Belgium
Jules Bordet Institute
Roche Pharma AG

Terminated

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 (I-SPARC)

Cancer

Belgium
Grand Hôpital de Charleroi

Completed

Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members

Covid19

Belgium
Grand Hôpital de Charleroi

Completed

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Covid19

Belgium
Brugmann University Hospital

Completed

Surgery in the Time of COVID-19 Pandemic

Covid19

Belgium
University Hospital, Ghent

Completed

Impact of COVID-19 on Mental Health of OCD Patients and live-in Family Members (COVIDOCS)

Obsessive-Compulsive Disorder

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Myocardial Contrast Echocardiography in Septic Patients

Sepsis | Microcirculation

Belgium
Jessa Hospital

Completed

Borderline COVID-19 PCR Test Result

Covid19 | Virus

Belgium
University of Liege

Completed

Psychosocial Outcomes in Families of COVID-19 ICU Patients

Critical Illness | Covid19 | Psychological Stress | Family

Belgium
Universiteit Antwerpen
University of Liege; Sciensano

Completed

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) (CHARMING)

COVID-19 | SARS-CoV-2

Belgium
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Typhoid Fever

Belgium
University Hospital, Ghent
Merck Sharp & Dohme LLC

Recruiting

Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade (SPARTACUS)

Peripheral Spondyloarthritis

Belgium
Cliniques universitaires Saint-Luc- Université...
Université Catholique de Louvain

Completed

Pharmacogenomics of New Antiretrovirals

HIV

Belgium
Universitair Ziekenhuis Brussel

Recruiting

poSt Covid-19 Infection centraL sENsitisaTion (SILENT 1)

Covid19

Belgium
University Hospital, Ghent

Withdrawn

Measuring the HIV-1 Reservoir During Cure Interventions Studies (MERCI)

Hiv

Belgium
University of Liege
Pfizer

Recruiting

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Coronavirus Disease 2019 (Covid19) | Hematopoietic Neoplasms

Belgium
GlaxoSmithKline
Novartis Vaccines

Completed

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Streptococcal Infections | Infections, Streptococcal

United States, Belgium, Czechia
Novartis

Completed

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Typhoid Fever

Belgium
Hasselt University
Ziekenhuis Oost-Limburg

Unknown

Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study (SCOUT)

COVID-19 Pneumonia | Lung Ultrasound

Belgium
Jessa Hospital
Hasselt University

Completed

An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic (COVID-ONCO)

Covid19 | PROMs | Chemotherapeutic Toxicity | Oncology

Belgium
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation

Influenza A Virus

Belgium
Labo'Life

Terminated

Study of 2LHERP® in Genital Herpes Infections (HEARTH-GEN)

Herpes Simplex, Genital

Belgium
Novartis Vaccines

Completed

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

Pertussis | Whooping Cough | Tetanus | Diphtheria | Lockjaw

Belgium
University Hospital, Antwerp
Medtronic

Completed

Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias (CoViDEx)

Covid19 | Ventricular Arrythmia | Athletes Heart | Myocarditis Viral

Belgium
GlaxoSmithKline

Completed

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

Hepatitis B

Belgium, Canada, Sweden
University Ghent

Completed

Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis (LACRING01)

Vaginosis, Bacterial

Belgium
Pfizer

Completed

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

Hepatitis C

Belgium, Germany, United Kingdom
Pierre Van Damme
Centre Hospitalier Intercommunal Creteil; University of Bristol; University Ghent and other collaborators

Completed

Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers

Streptococcus Pneumoniae | Nasopharyngeal Carriage

Belgium
Dr Philippe CLEVENBERGH

Completed

Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.

Legionnaires' Disease

Belgium
NEAT ID Foundation
ViiV Healthcare

Completed

An Open-Label, Multi-Centre, Randomised, Switch Study to Evaluate the Virological Efficacy Over 96 Weeks Of 2-Drug Therapy With DTG/RPV FDC in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTIs Resistance Mutation K103N (WISARD)

HIV-1-infection

Spain, Belgium, France, Germany, Italy, United Kingdom
Labo'Life

Recruiting

Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. (PAPION)

Human Papilloma Virus

Belgium
International Partnership for Microbicides, Inc.

Completed

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

HIV

Belgium
University Ghent
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System.

Bacterial Vaginosis

Belgium
University Hospital, Ghent
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Novartis Vaccines; University... and other collaborators

Completed

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Prevention of Infections With Bordetella Pertussis

Belgium

3

Subscribe